Maxine L Hetherington MD

Pediatric Hematology & Oncology•Kansas City, MO

Associate Professor of Pediatrics, University MO-Kansas City

Join to View Full Profile

2401 Gillham RdKansas City, MO 64108
Phone+1 816-234-3265
Fax+1 816-302-9894

Education & Training

University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 1984 - 1987
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1978 - 1981
University of Tennessee Health Science Center College of MedicineClass of 1978
Memphis State UniversityBA, 1975

Certifications & Licensure

CA State Medical License 1987 - Present
MO State Medical License 1989 - 2026
KS State Medical License 1990 - 2025
TN State Medical License 1978 - 1992
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2021
America's Top Doctors for Cancer Castle Connolly, 2005-2021
Clinical Fellow American Cancer Society, 1984
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
Unknown status
Phase 3
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Start of enrollment: 2004 Mar 15
Completed
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
ACTIVE_NOT_RECRUITING
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 30
COMPLETED
PHASE3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission Start of enrollment: 2005 May 30
Completed
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Start of enrollment: 2006 Feb 20
Completed
Phase 3
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Start of enrollment: 2007 May 03
Completed
Phase 3
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Start of enrollment: 2007 Aug 06
ACTIVE_NOT_RECRUITING
PHASE3
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Nov 06
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2007 Mar 01
Completed
Phase 3
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 1, Phase 2
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 May 23
ACTIVE_NOT_RECRUITING
PHASE3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 30
COMPLETED
PHASE3
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases Start of enrollment: 2007 Dec 31
Completed
Phase 3
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin Start of enrollment: 2007 May 01
Completed
Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia Start of enrollment: 2008 Jan 01
Completed
Phase 2
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 May 06
COMPLETED
PHASE3
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Jan 15
COMPLETED
PHASE3
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Start of enrollment: 2009 Feb 10
Completed
Phase 3
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia Start of enrollment: 2008 Apr 01
Completed
Phase 2
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers Start of enrollment: 2008 Jun 02
Completed
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Start of enrollment: 2008 Jun 23
Completed
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
ACTIVE_NOT_RECRUITING
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Start of enrollment: 2009 Mar 09
Completed
Phase 3
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Start of enrollment: 2009 Mar 01
Completed
Phase 2
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
ACTIVE_NOT_RECRUITING
Collecting and Storing Tissue From Young Patients With Cancer Start of enrollment: 2007 Mar 05
ACTIVE_NOT_RECRUITING
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
RECRUITING
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
ACTIVE_NOT_RECRUITING
PHASE3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2009 Dec 21
Completed
Phase 3
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
ACTIVE_NOT_RECRUITING
PHASE3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Feb 01
Completed
Phase 2
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
ACTIVE_NOT_RECRUITING
PHASE3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
ACTIVE_NOT_RECRUITING
PHASE3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
ACTIVE_NOT_RECRUITING
PHASE3
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Start of enrollment: 2011 Aug 01
Completed
Phase 2
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 1
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma Start of enrollment: 2012 Jan 01
Completed
Phase 2
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
COMPLETED
PHASE3
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
ACTIVE_NOT_RECRUITING
PHASE3
Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents Start of enrollment: 2012 Apr 23
Completed
Not Applicable
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
COMPLETED
PHASE2
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma Start of enrollment: 2013 Dec 24
Completed
Phase 2
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

3 citations
Next-Generation Sequencing in the Diagnosis of Rare Pediatric Sinonasal Tumors.
Atif A. Ahmed, Divya S Vundamati, Midhat S. Farooqi, Elena Repnikova, Timothy P. Zinkus
Ear, Nose, & Throat Journal. 2021-06-01
14 citations
The Children's Oncology Group: Organizational Structure, Membership, and Institutional Characteristics.
Janice S. Withycombe, Todd A. Alonzo, Michele A Wilkins-Sanchez, Maxine Hetherington, Peter C. Adamson
Journal of Pediatric Oncology Nursing. 2019-01-01
68 citations
Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.
Atif A. Ahmed, Lei Zhang, Naresh Reddivalla, Maxine Hetherington
Pediatric Hematology and Oncology. 2017-06-29

Journal Articles

Treatment of Chest Wall Osteosarcoma Presenting as Second Primary after Treatment of Neuroblastoma
Knott EM, Shah SR, Jones G, Hetherington M, Sharp RJ, J Pediatr Surg, 1/1/2012
Neurodegenerative Central Nervous System Langenhans Cell Histiocytosis and Coincident Hydrocephalus Treated with Vincristine/cytosine Arabinoside
Allen CE, Flores R, Rauch R, Dauser R, Murray JC, Puccetti D, Hsu DA, Sondel P, Hetherington M, Goldman S, McClain KL, Pediatri Blood Cancer, 1/1/2010
Giant Ossifying Malignant Thymoma in a Child
Bikhchandani J, Valusek PA, Juang D, E O'Brien J Jr, Hetherington M, St Peter SD, J Pediatr Surg, 1/1/2010
Minimal Residual Disease Testing of Acute Leukemia by Flow Cytometry Immunophenotyping:A Retrospective Comparison of Detection Rates with Flow Cytometry DN...
Zwick D, Cooley L, Hetherington M, Laboratory Hematology, 1/1/2006
Having a Child Diagnosed with Cancer: An Assessment of Values from the Mother's Viewpoint
Ward-Smith P, Kirk S, Hetherington M, Hubble CL, JOPON, 1/1/2005
Carboxypeptidase-G2 Rescue in a Patient with High Dose Methotrexate-Induced Nephrotoxicity
Widemann BC, Hetherington ML, Murphy RF, Batis FM, Adamson PC, Cancer, 1/1/1995
Comparison between Flow Cytometry and Cyto Genetic Tumor Cell DNA Content Using a Simple Flow Sample Preparation Method: Ploidy Comparison of 86 Fresh Pediatric Tumors
Zwick D, Morgan R, Pasztor L., Harris D, Hetherington M, Zalles C, Garola R, Ped Path Lab Med, 1/1/1995
Granulocyte-macrophage Colony Stimulating Factor Is an Endogenous Regulator of Cell Proliferation in Juvenile Chronic Myelogenous Leukemia
Gualtieri RJ, Emanuel PD, Zuckerman KS, Martin G, Clark SC, Shadduck RK, Dracker RA, Akabutu J, Nitschke R, Hetherington ML, Dickerman JP, Hakami N, Castleberry RL, Blood, 1/1/1989
Elevated Serum Transaminase Values during Therapy for Acute Lymphoblastic Leukemia Correlate with Prior Blood Transfusions
Hetherington ML, Buchanan GR, Cancer, 1/1/1988
Surveillance of Terminal Deoxynucleotidyl Transferase (TdT+)-containing Peripheral Blood Mononuclear Cells in Acute Lymphoblastic Leukemia: Low Sensitivity and Specif...
Hetherington ML, Huntsman RP, Smith RG, Buchanan GR, Leuk Res, 1/1/1987
Join now to see all

Books/Book Chapters

Minimal Residual Disease in Acute Leukemia
Chapter: Surveillance of Terminal Deoxynucleotidyl Transferase-positive Cells in Peripheral Blood of Patients with Acute Lymphoblastic Leukemia
Page 134 - 140Smith RG, Hetherington ML, Huntsman PR, Buchanan GREditors: Hagenbeek A, Lowenberg B.Martinus Nijhoff, Boston1986

Abstracts/Posters

Risk Factor Analysis and EBV Load surveillance in Pediatric Bone Marrow Tranplant Recipients
Dalal J, Rangaraj S, Gonzalez C, Anthony K, Liewer S, Jones R, Shreve N, Kranz K, Chignola B, Ryan R, Manalang M, Hetherington M, Gamis A Peters C, American Society for Blood and Marrow Transplantation, 1/1/2008
Minimal Residual Disease (MRD) Testing of Acute Leukemia by Flow Cytometry Immunophenotyping (FCIP): A Retrospective Comparison of Detection Rates with Flow Cytometry ...
Zwick D, Cooley L, Hetherington M, XVIIIth International Symposium on Technological Innovations in Laboratory Hematology, 1/1/2005
A Child's Diagnosis of Cancer Impacts Parental Values: A Qualitative Study
Ward-Smith P, Kirk S, Hetherington M, Hubble C, National Congress on the State of the Science in Nursing Research, 1/1/2004
Dual Cycle High-dose Chemotherapy with Stem Cell Rescue for Recurrent Brain Tumors
Gilman A, Bunin N, Levine J, Joyce M, Anderson P, Bendel A, Pietryga D, Anderson R, Goldman F, Rozans M, Sambrano J, Kadota R, Hetherington M, American Society Pediatric Hematology/Oncology, Thirteenth Annual Meeting, 1/1/2000
Outcome of Children's Cancer Group (CCG) 5941: A Pilot Study for the Treatment of Newly Diagnosed Pediatric Patients with Disseminated Lymphoblastic Lymphoma
Abromowitch M, Sposto R, Perkins S, Hetherington M, Meadows AT, Finlay J, Proc AACO, 1/1/2000
Peripheral Blood Progenitor Cell Pheresis (PBP) In Pediatric Patients - Laboratory and Clinical Parameters
Gamis A, Krueger K, Hetherington M, Watanabe M, Summers T, Parrish B, Graves B, Edwards R, Tilzer L, Marrow Transplantation in Children, 1/1/1995
Carboxypeptidase-G2 as a Rescue Agent Following Methotrexate Induced Renal Failure or Intrathecal Methotrexate Overdose
Widemann BC, Hetherington ML, Smithson WA, Murphy RF, Balis FM, Adamson PC, Proc AACR, 1/1/1995
Preliminary Results: Diffuse Intrinsic Brain Stem Gliomas of Childhood Respond to Tamoxifen - An Original Observation
Egelhoff JC, Freeman AI, Hetherington ML, Hanson EJ, Pons, M, SPR 37th Annual Meeting, Colorado Springs, Colorado, 1/1/1994
Preliminary Results: Diffuse Intrinsic Brain-Stem Gliomas of Childhood Respond to Tamoxifen
Hornig GW, Hanson EJ, Freeman A, Hetherington M, Ped N Surg, 1/1/1994
Continuous Infusion (CI) Vincristine (VCR) In Severe Refractory Acute ImmuneThrombocytopenic Purpura (ITP)
Gamis A, Flint M, Hetherington M, Blood, 1/1/1994
Presentation of a New Factor VIII Inhibitor with an Intraspinal Bleed
Wicklund B, Johnson J, Hetherington M, Wright W, Spoor M, McEntire J, 2nd International Symposium on Inhibitors to Coagulation Factors, Chapel Hill, NC, 1/3/1993
Evolution of Central Diabetes Insipidus in Langerhans Cell Histiocytosis
Schwartz ID, Hetherington M, Pediatr Res, 1/1/1993
Kinetics of Response to Therapy in Monosomy 7
Harris DJ, Bowe A, Lim C, Zusponn J, Hetherington M, Am J Hum Genetics, 1/1/1992
Treatment of Acute Immune Thrombocytopenic Purpura (ITP) in Children
Riddler SA, Watanabe M, Freeman AI, Wicklund BM, Hetherington ML, Woods GM, Pediatr Res, 1/1/1991
Cell Proliferation in Juvenile Chronic Myelogenous Leukemia (JCML) Is Regulated by Endogenously Produced Granulocyte-macrophage Colony Stimulating Factor (GM-CSF)
Emanuel PD, Castleberry RP, Zuckerman KS, Martin G, Clark SC, Shadduck RK, Dracker RA, Akabuti JJ, Nitschke R, Hetherington ML, Hakami N, Gualtieri RJ, Blood, 1/1/1988
Surveillance of Terminal Deoxynucleotidyl Transferase-containing (TdT+) Blood Cells in First Remission of Acute Lymphoblastic Leukemia (ALL): Low Sensitivity and Spec...
Hetherington ML, Huntsman PR, Smith RG, Buchanan GR, Pediatr Pathol, 1/1/1987
Transaminase Elevation during Therapy for Acute Lymphoblastic Leukemia (ALL) Correlates with Prior Transfusion of Blood Products
Hetherington ML, Buchanan GR, Clin Res, 1/1/1987
Transaminase Elevation during Therapy for Acute Lymphoblastic Leukemia (ALL) Correlates with Prior Transfusion of Blood Products
Hetherington ML, Buchanan GR, Sartain P, Blood, 1/1/1986
Terminal Deoxynucleotidyl Transferase-containing (TdT+) Peripheral Blood Cells of Children with Acute Lymphoblastic Leukemia (ALL)
Hetherington ML, Huntsman PR, Smith RG, Buchanan GR, Proc Am Soc Clin Oncol, 1/1/1986
Surveillance of Terminal Deoxynucleotidyl Transferase-containing Cells in the Peripheral Blood of Patients with Acute Lymphoblastic Leukemia
Hetherington ML, Huntsman PR, Smith RG, Buchanan GR, Blood, 1/1/1985
Join now to see all